Skip to main content

MORGAN STANLEY

Position in ENGN — enGene Therapeutics Inc.

CIK 895421 NEW YORK, NY

Position in ENGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$57,236
-$532,509 QoQ
Shares Held
33,086
-61.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 60 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ENGN ranks #369 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,236 33,086
2026-03-31 $589,745 86,600
2025-12-31 $6,487,918 718,485
2025-09-30 $2,973,037 435,291
2025-06-30 $1,284,074 352,768
2025-03-31 $1,955,806 436,564
2024-12-31 $2,917,833 438,772
2024-09-30 $54,073 8,193
2024-06-30 $546 58
2024-03-31 $135 8
2023-12-31 $73 8